Zidovudine
- Product NDC
- 67046-1613
- 11-digit product format
- 670461613
- Labeler code
- 67046
- Product ID
- 67046-1613_48c0ccac-2fe3-0fe2-e063-6294a90a2a9c
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Zidovudine
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Coupler LLC
- Application
- ANDA090092
- Marketing category
- ANDA
- Marketing start
- 2025-11-13
- Substance
- ZIDOVUDINE
- Active strength
- 300 mg/1
- Pharmacologic classes
- Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Zidovudine
- Listing expiration
- 2027-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| ZIDOVUDINE | 300 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 4B9XT59T7S |
| Rxcui | 199663 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 67046-1613-3 | Zidovudine | 30 in 1 BLISTER PACK | TABLET | 30 | | 2 |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 67046-1613-3 | 67046161303 | 30 TABLET in 1 BLISTER PACK (67046-1613-3) | 30 tablet | 2025-11-13 | No | No | Historical |